PRIMARY ANGIOPLASTICS AND PHARMACOINVASIVE REPERFUSION IN MYOCARDIAL INFARCTION: IMPACT ON CLINICAL OUTCOMES AND NO-REFLOW PHENOMENON

PRIMARY ANGIOPLASTICS AND PHARMACOINVASIVE REPERFUSION IN MYOCARDIAL INFARCTION: IMPACT ON CLINICAL OUTCOMES AND NO-REFLOW PHENOMENON

Bibliographic Details
Main Authors:	E. V. Vyshlov, D. S. Sevastyanova, A. A. Krylov, V. A. Markov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2015-02-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	острый инфаркт миокарда тромболитическая терапия фармакоинвазивная реперфузия феномен no-reflow
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/113

Similar Items

Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment
by: T. Yu. Mamonova, et al.
Published: (2009-04-01)

Thrombolytic therapy and cardiac free wall rupture in patients with acute myocardial infarction
by: E M Zeltyn-Abramov, et al.
Published: (2009-03-01)

Trimetazidine effects on red blood cell membrane lipids and necrosis area size in thrombolytic therapy of myocardial infarction
by: T. Yu. Rebrova, et al.
Published: (2009-04-01)

Шкала оценки риска феномена no-reflow при чрескожных коронарных вмешательствах у пациентов с острым инфарктом миокарда с подъемом сегмента ST
by: И. Бессонов, et al.
Published: (2020-11-01)

Effectiveness of deferred coronary artery stenting in the prevention of no-reflow in patients with acute ST-segment elevation myocardial infarction
by: A. V. Azarov, et al.
Published: (2021-03-01)

Intracoronary epinephrine and verapamil in the refractory no-reflow phenomenon in patients with acute myocardial infarction
by: S. V. Dil, et al.
Published: (2022-01-01)

Clinical effectiveness of thrombolytic therapy with alteplase and double antiplatelet therapy in acute myocardial infarction
by: D. N. Kuznetsov, et al.
Published: (2011-12-01)

Pre-hospital management of acute coronary syndrome
by: S. N. Tereshchenko, et al.
Published: (2009-06-01)

Use of pharmacoinvasive approach to the treatment of patients with ST segment elevation acute coronary syndrome: state of the problem
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

RESULTS OF TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DATA OF A RETROSPECTIVE, SINGLE-CENTER STUDY (IN-HOSPITAL PERIOD)
by: D. B. Nemick, et al.
Published: (2015-12-01)

Delayed endovascular surgery in patients with acute ST-segment elevation myocardial infarction due to massive culprit arterial thrombosis in the prevention of slow/no-reflow phenomenon
by: A. V. Azarov, et al.
Published: (2021-09-01)

THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION
by: D. P. Sementsov
Published: (2015-12-01)

Perftoran therapy perspectives in reperfusion syndrome prevention among acute myocardial infarction patients
by: S. S. Shuvalov, et al.
Published: (2006-08-01)

Low-molecular heparins in thrombolytic therapy of myocardial infarction patients
by: I. S. Yavelov
Published: (2009-12-01)

Comparing effectiveness of tissue and plasma plasminogen activator thrombolysis in patients with various severity of acute myocardial infarction
by: V. A. Shulman, et al.
Published: (2005-12-01)

EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION
by: P. G. Kesov, et al.
Published: (2015-09-01)

INFLUENCE OF RETHROMBOSIS OF INFARCTION-RELATED ARTERY AFTER THROMBOLYSIS ON SHORTEST TERM AND LONG TERM PROGNOSIS OF ST ELEVATION MYOCARDIAL INFARCTION
by: E. A. Shigotarova, et al.
Published: (2017-08-01)

Novel Aspects of Cardiac Ischemia and Reperfusion Injury Mechanisms
by: T. A. Yagudin, et al.
Published: (2019-01-01)

CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE
by: K. A. Kireev, et al.
Published: (2015-09-01)

Clopidogrel effects on thrombolysis effectiveness and clinical course of ST elevation myocardial infarction (30-day follow-up)
by: S. V. Shalaev, et al.
Published: (2007-08-01)

Comparative analysis of intramyocardial autotransplantation of postnatal stem cells from peripheral blood and adipose tissue in patients with acute phase of myocardial infarction, ST segment elevation, after effective thrombolytic reperfusion and coronary artery stenting
by: A. N. Kharlamov, et al.
Published: (1970-01-01)

CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01)

Primary angioplasty and pharmaco-invasive strategies in the treatment of ST-elevated myocardial infarction
by: M. G. Glezer, et al.
Published: (2019-04-01)

City: 10-year data of the MI register
by: A. A. Garganeeva, et al.
Published: (2009-02-01)

Changes in pattern of complications in acute myocardial infarction over a ten-year follow-up: gender specificities
by: S. A. Okrugin, et al.
Published: (2020-07-01)

PREVENTION OF COMPLICATIONS CAUSED BY MYOCARDIAL ISCHEMIA-REPERFUSION IN NONCARDIAC SURGICAL PROCEDURES
by: I. A. Kozlov
Published: (2016-06-01)

High-dose simvastatin therapy effectiveness in early post-infarction angina treatment
by: A. G. Nikishin, et al.
Published: (2011-10-01)

EXPERIENCE OF USING MECHANICAL THROMBECTOMY IN A PATIENT WITH SEVERE STROKE AND SEVERE COMORBID PATHOLOGY TAKING ANTICOAGULANTS
by: Марина Анатольевна Пеганова, et al.
Published: (2022-06-01)

Шкала оценки тяжести коронарной микрососудистой обструкции (no-reflow) при чрескожных коронарных вмешательствах у пациентов с инфарктом миокарда
by: A.A. Frolov, et al.
Published: (2023-12-01)

The Clinical Efficaciency and the Cost-Effectiveness of Reperfusion Therapy in Myocardial Infarction
by: A. M. Nazarov, et al.
Published: (2015-10-01)

TO THE QUESTION OF EFFICACY AND SAFETY OF FORTELYZIN® THERAPY ON ACUTE CORONARY SYNDROME: TWO CLINICAL CASES
by: D. S. Yunevich, et al.
Published: (2018-03-01)

Refractory post-infarction myocardial ischemia: treatment potential
by: V. V. Ryabov, et al.
Published: (2011-08-01)

COMBINED INTERVENING THERAPY OF BRAIN INFARCTION IN THE MIDDLE CEREBRAL ARTERY CIRCULATION
by: V. A. Saskin, et al.
Published: (2017-12-01)

The Analysis of the Risk Factors of Adverse Prognosis of Myocardial Infarction in the Acute Period
by: A. E. Zakharova, et al.
Published: (2016-02-01)

CLINICAL AND MEDICAL HISTORY FEATURES OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH DIABETES MELLITUS. EPIDEMIOLOGY STUDY
by: S. A. Okrugin, et al.
Published: (2017-12-01)

Acute myocardial infarction: gender specifics of development and clinical course in an urban Western Siberian population
by: A. A. Garganeeva, et al.
Published: (2012-06-01)

THE SPEKL-TREKING PREDICTIVE VALUE OF THE ECHOCARDIOGRAPHY AT THE ACUTE MYOCARDIAL INFARCTION
by: N. A. Kosheleva, et al.
Published: (2016-10-01)

THE EFFECTIVENESS OF PRECONDITIONING AND POSTCONDITIONING WITH ADENOSINE IN PREVENTION OF REPERFUSION DAMAGE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: N. T. Vatutin, et al.
Published: (2018-02-01)

Cytokines and autologic bone marrow mononuclears in postmyocardial infarction regeneration
by: V. V. Ryabov, et al.
Published: (2007-10-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)